Focus Stocks
Bears Appeared - Merck
Published on Thursday, 02 February 2012 18:42 Written by TradersHuddle Staff
New York, February 2nd (TradersHuddle.com) - Shares of Merck & Co. Inc. (NYSE:MRK) ended the trading session lower by $0.22 or -0.56% from its previous close. Merck's price action formed what is considered to be a bearish engulfing candlestick chart pattern.
Merck & Co., Inc. (NYSE:MRK), the global pharmaceutical company that develops, manufactures, and markets a broad range of human and animal health products. Merck's products include Zocor for treatment of elevated cholesterol, Propecia for treatment for male pattern hair loss, Fosamax for preventive treatment of osteoporosis, and Singulair for treatment of asthma. Merck was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Merck's current stock range is defined by calculated support defined at $33.13 and by the resistance level at $39.00, which should be used by traders planning their trades.
Traders wanting to establish a position in Merck stock need to pay close attention at the bearish engulfing pattern, since it could mark a trend reversal to current Merck shares price action. The Bearish engulfing pattern is a leading warning sign, therefore traders should closely monitor price action for indications of a trend reversal. Below an Engulfing Bearish Candle Illustration:

Related Articles
- Trading Idea: - Is Merck close to Resistance?
- Blood Sugar Basics Game Plan Now Available to Help Patients Tackle Type 2 Diabetes
- Merck Announces Third-Quarter 2012 Dividend
- FDA Approves New Labeling for ISENTRESS® (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated Adult Patients Infected with HIV-1
- Merck to Present at Bank of America Merrill Lynch 2012 Healthcare Conference
- Merck Is Approaching its 50 Day Moving Average
- Dow's Top Performers :CSCO, MRK, TRV
- Trading Idea: - Is Merck close to Resistance?
- Key Levels for Merck
- Merck to Present at Deutsche Bank 37th Annual Health Care Conference
Related Partner Headlines
- Merck & Co Inc (MRK): Today's Featured Drugs Winner - TheStreet.com
- Merck: FDA Approves New Labeling for ISENTRESS to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability - Benzinga
- Merck & Co Inc (MRK): Today's Featured Drugs Winner - TheStreet.com
- Dow Today: Merck (MRK) Higher - TheStreet.com
- Merck & Co Inc (MRK): Today's Featured Drugs Loser - TheStreet.com
- J.P. Morgan Reiterates Overweight Rating for Merck - Benzinga
- Goldman Sachs Reiterates Neutral Rating for Merck - Benzinga
- Use a Barbell Approach for Weighty Gains - TheStreet.com
- Merck Worth $41 on Solid Growth, Cost Controls - TheStreet.com
- Merck Reaches New 52-Week High (MRK) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
The EPA's Dangerous Game - TheStreet.com -
Sticking with the Preferred Plan - TheStreet.com -
Infoblox Posts Blowout Earnings; Shares Rise - TheStreet.com -
AutoZone Inc (AZO): Today's Featured Retail Loser - TheStreet.com -
Royal Bank Of Canada (RY): Today's Featured Banking Loser - TheStreet.com -
Salesforce.com Inc. (CRM): Today's Featured Computer Software & Services Loser - TheStreet.com -
CNH Global NV (CNH): Today's Featured Industrial Loser - TheStreet.com -
Warner Chilcott PLC (WCRX): Today's Featured Health Care Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Magna International Inc. to Contact the Firm -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Nokia Corporation to Contact the Firm -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Allscripts Healthcare Solutions, Inc. to Contact the Firm -
Thermal-Aid Bears Make Their Way to Children at City of Hope -
Ontraport Named a Top Finalist of CareerBuilder's First Annual "Big Strides in Small Business Award" -
CME Group Announces Five-for-One Stock Split -
Hancock Holding Company Announces Quarterly Dividend -
Lighting Science Group’s Board of Directors Announces Appointment of Steve Marton as Interim CEO Following Resignation of James Haworth









